Details for New Drug Application (NDA): 209335
✉ Email this page to a colleague
The generic ingredient in OXYBUTYNIN CHLORIDE is oxybutynin chloride. There are sixteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the oxybutynin chloride profile page.
Summary for 209335
Tradename: | OXYBUTYNIN CHLORIDE |
Applicant: | Abhai Llc |
Ingredient: | oxybutynin chloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 209335
Mechanism of Action | Cholinergic Muscarinic Antagonists |
Suppliers and Packaging for NDA: 209335
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET;ORAL | 209335 | ANDA | KVK-Tech, Inc. | 10702-201 | 10702-201-01 | 100 TABLET in 1 BOTTLE, PLASTIC (10702-201-01) |
OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET;ORAL | 209335 | ANDA | KVK-Tech, Inc. | 10702-201 | 10702-201-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (10702-201-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Dec 22, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription